Why is Balaxi Pharma falling/rising?

As of 29-Jul, Balaxi Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 47.85, which reflects a decrease of 0.77 or 1.58%. The stock has hit a new 52-week low of Rs. 47.75 today and has underperformed its sector by 1.74%. Over the past week, the stock has decreased by 2.19%, and it has shown a significant decline of 60.09% over the past year. Despite having strong long-term fundamentals, including a healthy average Return on Equity (ROE) of 30.97% and impressive growth in net sales and operating profit, the stock's recent performance has been adversely affected by a 31.3% drop in profits over the past year. Additionally, the stock is trading below all key moving averages, indicating a bearish trend.
In the broader market context, Balaxi Pharmaceuticals has underperformed compared to the Sensex, which has seen a slight decline of 0.96% over the past week and a modest gain of 4.97% year-to-date. The stock's long-term performance has also lagged behind the BSE500 index, further contributing to investor sentiment that may be driving the stock's decline. While there has been a notable increase in investor participation, as evidenced by a 141.91% rise in delivery volume, the overall negative returns and flat results in recent financial periods suggest that investors remain cautious about the stock's future performance.